JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rini, J. N.
Right arrow Articles by Palestro, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rini, J. N.
Right arrow Articles by Palestro, C. J.
Journal of Nuclear Medicine Vol. 44 No. 7 1072-1074
© 2003 by Society of Nuclear Medicine


Brief Communications

18F-FDG PET Versus CT for Evaluating the Spleen During Initial Staging of Lymphoma

Josephine N. Rini, MD1, John C. Leonidas, MD2, Maria B. Tomas, MD1 and Christopher J. Palestro, MD1

1 Division of Nuclear Medicine, Long Island Jewish Medical Center, New Hyde Park, New York
2 Pediatric Radiology, Long Island Jewish Medical Center, New Hyde Park, New York

ABSTRACT

The purpose of this study was to compare 18F-FDG PET to CT for evaluating the spleen during the initial staging of lymphoma. Methods: Seven patients with newly diagnosed lymphoma underwent 18F-FDG PET and CT. Splenic uptake of 18F-FDG, diffuse or focal, greater than hepatic uptake was interpreted as consistent with tumor. CT demonstrating a positive splenic index or focal hypodensities was classified as positive for tumor. PET and CT results were compared with final diagnoses, which were confirmed surgically for 6 patients and at autopsy for 1 patient. Results: Five of 7 patients had lymphomatous involvement of the spleen. 18F-FDG PET was true-positive for all 5 patients with splenic disease and true-negative for both patients without splenic disease. CT, in contrast, was true-positive for 4 of the 5 patients with splenic disease and false-positive for the 2 patients without splenic disease. The accuracies of 18F-FDG PET and CT for evaluating the spleen were 100% and 57%, respectively. Conclusion:18F-FDG PET correctly identified all patients with and without splenic disease and was superior to CT for this purpose.

Key Words: 18F-FDG PET • lymphoma staging • splenic lymphoma




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
W.-K. Lee, E. W. F. Lau, V. A. Duddalwar, A. J. Stanley, and Y. Y. Ho
Abdominal Manifestations of Extranodal Lymphoma: Spectrum of Imaging Findings
Am. J. Roentgenol., July 1, 2008; 191(1): 198 - 206.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
U. Metser, E. Miller, A. Kessler, H. Lerman, G. Lievshitz, R. Oren, and E. Even-Sapir
Solid Splenic Masses: Evaluation with 18F-FDG PET/CT
J. Nucl. Med., January 1, 2005; 46(1): 52 - 59.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.